"New Jersey, June 13, 2022 - Freyr announced that a leading global Bio-pharmaceutical company selected Freyr IMPACT as its global Regulatory Intelligence (RI) solution to transform their current Regulatory Intelligence ecosystem.

Imagine if a major web-based collaborative platform application that you use currently does not integrate with any other systems and requires a magnificent amount of manual intervention at this age! Wouldn’t it be challenging? The Biopharma leader had similar challenges, as their application was at an end-of-life position and was not capable of capturing global Health Authority requirements in real-time. In addition, the customer wanted to replace multiple applications and file-based data management tools with a centralized platform.

Consequently, the selection of Freyr IMPACT came natural for the Pharma company for automated data capturing, cleansing, and managing changing global Regulatory requirements, including policies, guidance documents, etc. On the other hand, it was to enable critical decision-making processes and introduce innovative technologies, including robotic process automation/AI/ML.

With a centralized repository, global dashboard, actionable insights, SME synopsis, and recommendations, Freyr IMPACT is all set to transform the customer’s Regulatory Intelligence ecosystem, and the scope of migrating 2.9 Mn+ records stand as a key highlight of the project.

“An opportunity to collaborate with a Pharma giant in the Regulatory Intelligence space is an absolute privilege and this being initiated with digital automation technology is something we really look forward to as we believe the digital transformation in Life Sciences is the next big thing,” said Suren Dheenadayalan, CEO, Freyr Solutions. “We are highly positive that this partnership will enable the customer to meet the global Regulatory Intelligence requirements and enhance their decision-making in creating meticulous market strategies,"" added Suren."